Tolerability of aztreonam and carbapenems in patients with IgE-mediated hypersensitivity to penicillins
- 1 April 2015
- journal article
- research article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 135 (4) , 972-976
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Absence of cross-reactivity to carbapenems in patients with delayed hypersensitivity to penicillinsAllergy, 2013
- Safely Diagnosing Clinically Significant Penicillin Allergy Using Only Penicilloyl-Poly-Lysine, Penicillin, and Oral AmoxicillinThe Journal of Allergy and Clinical Immunology: In Practice, 2013
- Diagnosis and management of drug hypersensitivity reactionsJournal of Allergy and Clinical Immunology, 2011
- Drug Allergy: An Updated Practice ParameterAnnals of Allergy, Asthma & Immunology, 2010
- Tolerability of imipenem in children with IgE-mediated hypersensitivity to penicillinsJournal of Allergy and Clinical Immunology, 2009
- Tolerability of meropenem in children with IgE‐mediated hypersensitivity to penicillinsAllergy, 2008
- Brief Communication: Tolerability of Meropenem in Patients with IgE-Mediated Hypersensitivity to PenicillinsAnnals of Internal Medicine, 2007
- Cross-Reactivity and Tolerability of Cephalosporins in Patients with Immediate Hypersensitivity to PenicillinsAnnals of Internal Medicine, 2004
- Imipenem cross-reactivity with penicillin in humansJournal of Allergy and Clinical Immunology, 1988
- Immunology of the monobactam aztreonamAntimicrobial Agents and Chemotherapy, 1984